Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.24.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 2,113 $ 3,498
Accounts receivable, net of allowance for credit loss of $26 and $0, respectively 7,293 4,983
Other current assets 1,704 1,841
Total current assets 11,110 10,322
Property and equipment, net 1,352 790
Operating lease right of use assets 1,532 1,864
Other long-term assets 45 45
Total assets 14,039 13,021
Current liabilities:    
Accounts payable 1,701 1,544
Accrued salary and bonus 1,687 1,969
Other accrued expenses 9,033 8,201
Note payable at fair value, current 5,688 5,100
Current liabilities of discontinued operations 660 660
Total current liabilities 18,769 17,474
Operating lease liabilities, net of current portion 1,189 1,472
Note payable at fair value 4,243
Other long-term liabilities 5,227 4,968
Total liabilities 25,185 28,157
Commitments and contingencies (Note 8)
Redeemable preferred stock, $.01 par value; 5,000,000 shares authorized,47,000 shares Series B issued and outstanding 46,536 46,536
Stockholders’ deficit:    
Common stock, $.01 par value; 100,000,000 shares authorized; 4,532,991 and 4,447,489 shares issued, respectively; 4,404,795 and 4,351,445 shares outstanding, respectively 406 405
Additional paid-in capital 188,363 188,146
Accumulated deficit (244,405) (248,215)
Treasury stock, at cost (128,196 and 96,044 shares, respectively) (2,046) (2,008)
Total stockholders’ deficit (57,682) (61,672)
Total liabilities and stockholders’ deficit (32,497) (33,515)
Total liabilities, preferred stock and stockholders’ deficit $ 14,039 $ 13,021